These contradictory findings might in part be due to the different types of tumors in these reports, where E2F2 functioned as a tumor suppressor in Myc-induced cancers [35,36] and exerted a strong oncogenic effect in lung cancer and glioblastoma cells [33,34]. The gene discussed is MYC; the disease is cancer.